Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000053417-25-000074·JENNISON ASSOCIATES LLC
Schedule 13G ownership disclosure
Phathom Pharmaceuticals Inc
Common Stock · CUSIP: 71722W107
Event date: 2025-05-31
- Filing-level shares
- 0
- Percent of class
- 0%
- Jennison Associates LLC
Shares: 0 · Class: 0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000053417-25-000074
- Form type
- SCHEDULE 13G/A
- Filer
- JENNISON ASSOCIATES LLC
- CIK
- CIK 53417
- Filed
- Jun 09, 2025
- Reporting period
- May 31, 2025
- Description
- Schedule 13G beneficial ownership